Sector Chart Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
04:00:00 29/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 43.25 USD | +1.79% |
|
+0.58% | -1.82% |
| 10-28 | Scholar Rock Holding Insider Bought Shares Worth $11,999,922, According to a Recent SEC Filing | MT |
| 10-08 | Scholar Rock Resubmits Apitegromab Application in EU for Spinal Muscular Atrophy | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 5.17B | - | - | - | - | - |
| 63.48B | |||||
| 54.55B | |||||
| 53.59B | |||||
| 44.75B | |||||
| 41.62B |
Select your edition
All financial news and data tailored to specific country editions
